17
Nov 2026
Nearly 75% of deceased NFL players had CTE pathology
A bias-adjusted study estimates CTE neuropathology in 74.5% of deceased former NFL players, suggesting donation bias does not explain its high prevalence.
17
Nov 2026
A bias-adjusted study estimates CTE neuropathology in 74.5% of deceased former NFL players, suggesting donation bias does not explain its high prevalence.
17
Nov 2026
Enterprise Therapeutics Ltd (Enterprise), a biopharmaceutical company dedicated to the discovery and development of novel therapies to improve the lives of people with respiratory diseases, today announced that the European Medicines Agency (EMA) Committee for Orphan Medicinal Products (COMP) has granted ETD001 designation as an orphan medicinal product for the treatment of cystic fibrosis.
17
Nov 2026
Nuclera, the biotechnology company enabling access to innovative protein technologies, today announced the publication of research conducted in collaboration with researchers at the University of Cambridge's Department of Biochemistry, demonstrating a rapid, cell-free approach utilizing proprietary nanodisc technology to produce challenging protein drug-targets for high-resolution structural analysis.
17
Nov 2026
Calla Lily Clinical Care, a clinical-stage women's health company, today announced it has been awarded a £700 k Innovate UK grant through its Growth Catalyst: Investor Partnerships program, which pairs grant funding with matched private investment.
17
Nov 2026
Calla Lily Clinical Care, a clinical-stage women's health company, today announced it has been awarded a £700 k Innovate UK grant through its Growth Catalyst: Investor Partnerships program, which pairs grant funding with matched private investment.
17
Nov 2026
European survey data reveal uneven understanding of dementia subtypes, with awareness varying across English, German, Lithuanian, Polish, and Dutch groups.
17
Nov 2026
A treatment program from Black Dog Institute is giving hope to people with Premenstrual Dysphoric Disorder (PMDD), according to the results of a new study published in Behavior Research and Therapy.
17
Nov 2026
This interview explains how DDA and DIA affect spectral quality, identification, and quantitation in untargeted metabolomics and lipidomics.
17
Nov 2026
UK-first £10 million UKRI-backed program will take new therapeutics, medical devices and digital health tools for heart disease, diabetes and obesity, from development through real-world validation to adoption in the NHS, private healthcare and international markets.
17
Nov 2026
Rare Cancers Australia’s upcoming policy roundtable is particularly timely following the death of leading rare cancer advocate, Caitlin Delaney AM.
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more